References
- Sorbera LA, Leeson P, Castaner J, Castaner RM. Valdecoxib and parecoxib sodium: analgesic, antiarthritic, cyclooxygenase-2 inhibitor. Drugs Future 2001;26:133–140.
- Palomer A, Cabré F, Pascual J, Campos J, Trujillo MA, Entrena A et al. Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models. J Med Chem 2002;45:1402–1411.
- Motawi TK, Abd Elgawad HM, Shahin NN. Modulation of indomethacin-induced gastric injury by spermine and taurine in rats. J Biochem Mol Toxicol 2007;21:280–288.
- Verrico MM, Weber RJ, McKaveney TP, Ansani NT, Towers AL. Adverse Drug Events Involving COX-2 Inhibitors. Ann Pharmacother 2003;37:1203–1213.
- Dogné JM, Supuran CT, Pratico D. Adverse cardiovascular effects of the coxibs. J Med Chem 2005;48:2251–2257.
- Okushima H, Narimatsu A, Kobayashi M, Furuya R, Tsuda K, Kitada Y. A novel class of cardiotonics. Synthesis and pharmacological properties of [4-(substituted-amino)phenyl]pyridazinones and related derivatives. J Med Chem 1987;30:1157–1161.
- Robertson DW, Krushinski JH, Beedle EE, Wyss V, Pollock GD, Wilson H et al. Dihydropyridazinone cardiotonics: the discovery and inotropic activity of 1,3-dihydro-3,3-dimethyl-5-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-2H -indol-2- one. J Med Chem 1986;29:1832–1840.
- Yamada T, Nobuhara Y, Shimamura H, Yoshihara K, Yamaguchi A, Ohki M. Studies on new antiulcer agents. I. Synthesis and antisecretory activity of pyridazine derivatives. Chem Pharm Bull 1981;29:3433–3439.
- Matsuo T, Tsukamoto Y, Takagi T, Sato M. Synthesis and biological activity of pyridazinooxazines. Chem Pharm Bull 1982;30:832–842.
- Rubat C, Coudert P, Couquelet J, Bastide P, Bastide J. Synthesis and analgesic effect of N-substituted 5-arylidene-6-methyl-3-(4H)-pyridazinones. Chem Pharm Bull 1988;36:1558–1561.
- Rubat C, Coudert P, Tronche P, Bastide J, Bastide P, Privat AM. Synthesis and pharmacological evaluation of N-substituted 4,6-diaryl-3-pyridazinones as analgesic, antiinflammatory and antipyretic agents. Chem Pharm Bull 1989;37:2832–2835.
- Husain A, Alam MM, Siddiqui N. Synthesis, reactions and biological activity of 3-arylidene-5-(4-methylphenyl)-2(3H)-furanones. J Serb Chem Soc 2009;74:103–115.
- Alam MM, Husain A, Hasan SM, Suruchi, Anwer T. Synthesis and pharmacological evaluation of 2(3H)-furanones and 2(3H)-pyrrolones, combining analgesic and anti-inflammatory properties with reduced gastrointestinal toxicity and lipid peroxidation. Eur J Med Chem 2009;44:2636–2642.
- Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc Soc Exp Biol Med 1962;111:544–547.
- Siegmund E, Cadmus R, Lu G. A method for evaluating both non-narcotic and narcotic analgesics. Proc Soc Exp Biol Med 1957;95:729–731.
- Cioli V, Putzolu S, Rossi V, Scorza Barcellona P, Corradino C. The role of direct tissue contact in the production of gastrointestinal ulcers by anti-inflammatory drugs in rats. Toxicol Appl Pharmacol 1979;50:283–289.
- Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351–358.